loader image
Saturday, January 10, 2026
76 F
McAllen
- Advertisement -

Begley Contributes to Global Epilepsy Projects

Translate to Spanish or other 102 languages!

Charles E. Begley
Charles E. Begley

Mega Doctor News

- Advertisement -

As originally published in Mega Doctor News newsprint edition August 2018

Houston, Texas – Charles E. Begley, Ph.D., professor in the Department of Management, Policy and Community Health at UTHealth School of Public Health in Houston, has been invited to work on the Global Epilepsy Report sponsored by the World Health Organization, International League Against Epilepsy and the International Bureau for Epilepsy. Begley will serve on the editorial board for the report and as lead author of the chapter on health care response.

The purpose of the report is to raise awareness of the global burden of the disease and to identify and support possible approaches to enhance access to affordable epilepsy care and services. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally, according to the World Health Organization. Three-fourths of people with epilepsy living in low- and middle- income countries do not get the treatment they need.

- Advertisement -

“This report will provide background information and analysis leading to a global action plan for epilepsy (similar to existing plans for dementia, suicide, aging, and non-communicable diseases) with milestones, indicators, and targets to facilitate advocacy,” Begley says.

Begley also has been appointed co-chair of the International League Against Epilepsy’s Task Force on the Cost of Epilepsy. During the next four years, the task force will develop evidence-based estimates of the direct and indirect cost of epilepsy at the country, region and global levels based on reviews of the international cost literature and cost modeling.

Begley co-directs the Center for Health Services Research at UTHealth School of Public Health, which conducts research and provides technical assistance and training in the organization, financing, and outcomes of health services, systems, and policies. He has investigated the social and economic impact of epilepsy since 1994.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Backs Updated Dietary Guidelines, Commits to Advancing Nutrition in Medicine

“The American Medical Association (AMA) applauds the Administration’s new Dietary Guidelines for spotlighting the highly processed foods, sugar-sweetened beverages, and excess sodium that fuel heart disease, diabetes, obesity, and other chronic illnesses. The Guidelines affirm that food is medicine and offer clear direction patients and physicians can use to improve health."

Wegovy® Pill, First Oral GLP‑1 for Weight Loss, Now Available Nationwide

Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time.

Historic Reset of U.S. Nutrition Policy with New Food Pyramid

Mega Doctor News WASHINGTON, D.C. – U.S. Department of Health and Human Services...

Metabolic Trigger Identified That Shuts Down Key Tumor‑Fighting Gene

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center. 
- Advertisement -
×